A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies
Clinical trial NCT06668584 · RECRUITING
Trial details
- NCT number
- NCT06668584
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-31
- Primary completion
- 2027-12-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.